{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:36:07Z","timestamp":1761510967132,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.purol.2012.10.006","type":"journal-article","created":{"date-parts":[[2012,11,12]],"date-time":"2012-11-12T22:20:19Z","timestamp":1352758819000},"page":"1064-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Five years follow-up study and failures analysis of Botulinum toxin repeated injections to treat neurogenic detrusor overactivity"],"prefix":"10.1016","volume":"22","author":[{"given":"S.","family":"Gaillet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bardot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bernuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Boissier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lenne-Aurier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Thiry-Escudier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tournebise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lechevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Karsenty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.purol.2012.10.006_bib0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2012.10.006_bib0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.purol.2009.02.006","article-title":"Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity","volume":"19","author":"Perrouin-Verbe","year":"2009","journal-title":"Prog Urol"},{"issue":"1","key":"10.1016\/j.purol.2012.10.006_bib0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2009.04.028","article-title":"EAU guidelines on neurogenic lower urinary tract dysfunction","volume":"56","author":"Stohrer","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2012.10.006_bib0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/nau.20852","article-title":"Neurologic urinary incontinence","volume":"29","author":"Wyndaele","year":"2010","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.purol.2012.10.006_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","article-title":"Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report","volume":"55","author":"Apostolidis","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2012.10.006_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000052421","article-title":"Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen","volume":"39","author":"Costa","year":"2001","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2012.10.006_bib0035","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.annrmp.2005.02.011","article-title":"Symptom and quality of life assessment in urinary disorders","volume":"48","author":"Bonniaud","year":"2005","journal-title":"Ann Readapt Med Phys"},{"issue":"4","key":"10.1016\/j.purol.2012.10.006_bib0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2006.07.022","article-title":"Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: A critical analysis of results","volume":"50","author":"Patel","year":"2006","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2012.10.006_bib0045","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.juro.2010.12.002","article-title":"Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis","volume":"185","author":"Khan","year":"2011","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2012.10.006_bib0050","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","article-title":"Do repeat intradetrusor botulinum toxin type a injections yield valuable results?. Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity","volume":"52","author":"Reitz","year":"2007","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.purol.2012.10.006_bib0055","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.purol.2012.10.006_bib0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.annrmp.2007.03.019","article-title":"Efficacy of repeat injections of botulinum A toxin to the detrusor in neurogenic bladder overactivity","volume":"50","author":"Chenet","year":"2007","journal-title":"Ann Readapt Med Phys"},{"issue":"5","key":"10.1016\/j.purol.2012.10.006_bib0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","article-title":"Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre","volume":"53","author":"Del Popolo","year":"2008","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.purol.2012.10.006_bib0070","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","article-title":"Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low compliance bladder in patients with spinal cord lesions","volume":"86","author":"Klaphajone","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"issue":"8","key":"10.1016\/j.purol.2012.10.006_bib0075","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/nau.21124","article-title":"Repeated Botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele","volume":"30","author":"Horst","year":"2011","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.purol.2012.10.006_bib0080","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1166-7087(07)92370-2","article-title":"Pharmacological treatment of neurogenic detrusor hyperactivity: intradetrusor botulinum toxin A injections","volume":"17","author":"Karsenty","year":"2007","journal-title":"Prog Urol"},{"issue":"9","key":"10.1016\/j.purol.2012.10.006_bib0085","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/014107689208500906","article-title":"Botulinum toxin treatment of spasmodic torticollis","volume":"85","author":"Anderson","year":"1992","journal-title":"J Royal Soc Med"},{"issue":"2","key":"10.1016\/j.purol.2012.10.006_bib0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.870090216","article-title":"development of resistance to botulinum toxin type-a in patients with torticollis","volume":"9","author":"Greene","year":"1994","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.purol.2012.10.006_bib0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/exnr.1997.6580","article-title":"Botulinum a toxin therapy: Neutralizing and nonneutralizing antibodies-therapeutic consequences","volume":"147","author":"Goschel","year":"1997","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.purol.2012.10.006_bib0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1162\/152687401300343571","article-title":"Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia","volume":"2001","author":"Rollnik","year":"2001","journal-title":"Neur Clin Neurophysiol"},{"issue":"13","key":"10.1016\/j.purol.2012.10.006_bib0105","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/mds.23254","article-title":"Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX\u00ae) across multiple indications","volume":"25","author":"Naumann","year":"2010","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.purol.2012.10.006_bib0110","first-page":"964","article-title":"Motor-nerve sprouting in human orbicularis muscle after botulinum-a injection","volume":"31","author":"Holds","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.purol.2012.10.006_bib0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1442-2042.2008.02016.x","article-title":"Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure","volume":"15","author":"Schulte-Baukloh","year":"2008","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.purol.2012.10.006_bib0120","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000331726","article-title":"Results of a BoNT\/A antibody study in children and adolescents after onabotulinumtoxin A (Botox\u00ae) detrusor injection","volume":"87","author":"Schulte-Baukloh","year":"2011","journal-title":"Urol Int"},{"issue":"1","key":"10.1016\/j.purol.2012.10.006_bib0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.urology.2010.03.023","article-title":"Antibody formation following botulinum toxin type A (Dysport) injection in children with intractable bladder hyper-reflexia","volume":"76","author":"Kajbafzadeh","year":"2010","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.purol.2012.10.006_bib0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000332194","article-title":"Antibodies after botulinum toxin A injection into musculus detrusor vesicae: incidence and clinical relevance","volume":"87","author":"Hegele","year":"2011","journal-title":"Urol Int"},{"issue":"6","key":"10.1016\/j.purol.2012.10.006_bib0135","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","article-title":"Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity","volume":"53","author":"Apostolidis","year":"2008","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.purol.2012.10.006_bib0140","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","article-title":"Histologic features in the urinary bladder wall affected from neurogenic overactivity \u2013\u00a0a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A","volume":"50","author":"Comperat","year":"2006","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2012.10.006_bib0145","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2012.10.006_bib0150","article-title":"Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB)","author":"Mohee","year":"2012","journal-title":"BJU Int"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708712006094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708712006094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:21:59Z","timestamp":1761114119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708712006094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":30,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1166708712006094"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2012.10.006","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Five years follow-up study and failures analysis of Botulinum toxin repeated injections to treat neurogenic detrusor overactivity","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2012.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}